Kruger Kurt H
Insider CIK 1375881 · NONE Chief Financial Officer · QLGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| QLGN Qualigen Therapeutics, Inc | A Award deriv | 2022-07-11 | 2022-08-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | P Buy | 2021-08-19 | 2021-08-20 | 4,000 | $1.22 | $4.9K | 18,000 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | P Buy | 2021-08-19 | 2021-08-20 | 4,000 | $1.23 | $4.9K | 14,000 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | P Buy | 2020-12-29 | 2020-12-30 | 4,000 | $2.94 | $11.8K | 10,000 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | P Buy | 2020-11-23 | 2020-11-23 | 4,600 | $3.46 | $15.9K | 6,000 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | P Buy | 2020-11-20 | 2020-11-23 | 1,400 | $3.55 | $5.0K | 1,400 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | A Award deriv | 2020-06-06 | 2020-06-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | J Other deriv | 2020-05-22 | 2020-05-27 | 8,857 | — | $0 | 8,857 | SEC↗ |
| NONE EMMAUS LIFE SCIENCES, INC. | A Award deriv | 2018-08-16 | 2018-08-16 | 50,000 | — | $0 | 50,000 | SEC↗ |